Sumitomo Mitsui Trust Group
MEDP icon

Sumitomo Mitsui Trust Group’s Medpace MEDP Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.86M Sell
3,872
-1,055
-21% -$540K ﹤0.01% 796
2025
Q4 		$2.77M Buy
4,927
+3,627
+279% +$2.06M ﹤0.01% 771
2025
Q3 		$668K Buy
+1,300
New +$568K ﹤0.01% 897
2024
Q3 		– Sell
-1,756
Closed -$723K – 1086
2024
Q2 		$723K Hold
1,756
– – ﹤0.01% 931
2024
Q1 		$710K Sell
1,756
-300
-15% -$105K ﹤0.01% 991
2023
Q4 		$630K Buy
2,056
+856
+71% +$231K ﹤0.01% 1023
2023
Q3 		$291K Buy
+1,200
New +$307K ﹤0.01% 1089

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group's MEDP Position: Q1 2026 in Review

Sumitomo Mitsui Trust Group reduced its Medpace (MEDP) stake by 21% in Q1 2026, selling an estimated $540K and leaving 3,872 shares worth $1.86M. The position accounts for ﹤0.01% of the portfolio, ranked #796.

Sumitomo Mitsui Trust Group first reported a position in MEDP in Q3 2023 and has held it in 7 quarters since. The position peaked at $2.77M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Sumitomo Mitsui Trust Group held 3,872 shares of Medpace worth $1.86M as of Q1 2026.
  • Sumitomo Mitsui Trust Group sold 1,055 Medpace shares in Q1 2026, an estimated $540K.
  • Medpace made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #796 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Medpace in Q3 2023 and has held it in 7 quarters since.
  • Sumitomo Mitsui Trust Group's Medpace position peaked at $2.77M in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.